Opus Genetics's total assets for Q2 2024 were $44.83M, a decrease of -13.52% from the previous quarter. IRD total liabilities were $4.20M for the fiscal quarter, a -27.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.